PATTERNS OF CARE AND EXPENDITURES BY CALIFORNIA MEDICAID FOR PEPTIC-ULCER AND OTHER ACID-RELATED DISEASES

被引：14

作者：

BLOOM, BS

FOX, NA

JACOBS, J

机构：

[1] UNIV PENN,LEONARD DAVIS INST HLTH ECON,PHILADELPHIA,PA 19104

[2] PRACON INC,CTR ECON STUDIES MED,RESTON,VA

来源：

关键词：

D O I：

10.1097/00004836-198912000-00003

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：615 / 620

页数：6

共 10 条

[1] Bloom B S, 1989, Int J Technol Assess Health Care, V5, P215
[2] RISK AND COST OF GASTROINTESTINAL SIDE-EFFECTS ASSOCIATED WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
BLOOM, BS
[J]. ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (05) : 1019 - 1022
[3] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND PEPTIC-ULCER PERFORATION
COLLIER, DS
PAIN, JA
[J]. GUT, 1985, 26 (04) : 359 - 363
[4] COST-EFFECTIVENESS OF DUODENAL-ULCER TREATMENT
CULYER, AJ
MAYNARD, AK
[J]. SOCIAL SCIENCE & MEDICINE PART C-MEDICAL ECONOMICS, 1981, 15 (1C): : 3 - 11
[5] FINEBERG HV, 1981, LANCET, V1, P1305
[6] GRIFFIN MR, 1988, ANN INTERN MED, V109, P357
[7] JONSSON B, 1983, EC MED EVALUATION HL, P243
[8] CURRENT PEPTIC-ULCER TIME TRENDS - AN EPIDEMIOLOGICAL PROFILE
KURATA, JH
CORBOY, ED
[J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1988, 10 (03) : 259 - 268
[9] SOMERVILLE K, 1986, LANCET, V1, P462
[10] 1985, ANN INTERN MED, V102, P266